[Myelography with water-soluble contrast media in the diagnosis of space-occupying spinal lesions].
D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects; D004806:Ependymoma / Q000000981:diagnostic imaging; D006801:Humans; D007479:Iopamidol; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging; D008579:Meningioma / Q000000981:diagnostic imaging; D008793:Metrizamide / Q000009:adverse effects; D009192:Myelography; D013118:Spinal Cord Diseases / Q000000981:diagnostic imaging*; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging; D013122:Spinal Diseases / Q000000981:diagnostic imaging*
D003287:Contrast Media; D007483:Iothalamic Acid; D007479:Iopamidol; D008793:Metrizamide
Die Myelographie mit wasserlöslichen Kontrastmitteln in der Diagnostik raumfordernder spinaler Prozesse.